Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs https://medcitynews.com/2026/11/windward-bio-ipo-long-acting-antibody-tslp-asthma-copd-atopic-dermatitis-wwb/By Frame News, Nov 13, 2026. 2 likes, 0 comments.